Stay updated with breaking news from Quest Pharmatech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Photodynamic Therapy Market Overview, Component, Industry...
A MESSAGE FROM OUR CHIEF EXECUTIVE OFFICER June 30, 2023 Dear shareholders, ...
Share this article TSX Venture: QPT EDMONTON, AB, June 1, 2021 /PRNewswire/ - Quest PharmaTech Inc. (TSXV: QPT) ("Quest" or the "Company") announces that clinical investigators working with OncoQuest Pharmaceuticals, Inc. ("OQP") lead clinical candidate oregovomab, will be making two presentations as part of the American Society of Clinical Oncology (ASCO) conference proceedings. OQP acquired oregovomab from OncoQuest Inc., one of the equity investee comp...
Latest research study from JCMR with title Global Photodynamic Therapy Market by Manufacturers, Regions, Type and Application, Forecast to 2022-2029. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, facts, historical data, and statistically supported and industry validated market data. The study is segmented by products type & Applications. The research study provides estimates for and Photodynamic Therapy Market Forecast till 2029 Get Quick Free Sample Copy of Report @: Key Companies/players: Sanofi, D...
Share: TSX Venture: QPT EDMONTON, AB, Jan. 5, 2021 /CNW/ - Quest PharmaTech Inc. (TSXV:QPT) ("Quest") provides update to its June 4, 2020 news release to announce that one of its equity investee companies, OncoQuest Inc. ("OncoQuest"), completed the transfer of the immunotherapy technology assets to OncoQuest Pharmaceuticals, Inc, a KOSDAQ traded company ("OQP", 078590.KQ) on November 7, 2020. However, due to COVID-19 related Korean courts restrictions, final payment of 65,229,709 shares of OQP to OncoQuest has been delayed by one month from December 31, 2020 to January 31, 2021. In addition,...